121 related articles for article (PubMed ID: 38294129)
21. Effects of baicalin capsules combined with α-lipoic acid on nerve conduction velocity, oxidative stress and inflammatory injury in patients with diabetic peripheral neuropathy.
Tang C; Han R; Wu J; Fang F
Am J Transl Res; 2021; 13(4):2774-2783. PubMed ID: 34017440
[TBL] [Abstract][Full Text] [Related]
22. Diphenyl diselenide alleviates diabetic peripheral neuropathy in rats with streptozotocin-induced diabetes by modulating oxidative stress.
Wang X; Huan Y; Li C; Cao H; Sun S; Lei L; Liu Q; Liu S; Ji W; Liu H; Huang K; Zhou J; Shen Z
Biochem Pharmacol; 2020 Dec; 182():114221. PubMed ID: 32949583
[TBL] [Abstract][Full Text] [Related]
23. Biomarkers of response to alpha-lipoic acid ± palmitoiletanolamide treatment in patients with diabetes and symptoms of peripheral neuropathy.
Pieralice S; Vari R; Minutolo A; Maurizi AR; Fioriti E; Napoli N; Pozzilli P; Manfrini S; Maddaloni E
Endocrine; 2019 Nov; 66(2):178-184. PubMed ID: 30949911
[TBL] [Abstract][Full Text] [Related]
24. EFFECTIVENESS OF ALPHA-LIPOIC ACID AND IPIDACRINE HYDROCHLORIDE IN PREVENTION OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY ASSESSED BY ELECTRONEUROMYOGRAPHY OF SUPERFICIAL PERONEAL AND SURAL NERVES.
Holotiuk IS; Kryzhanivska AY; Holotiuk SI; Holotiuk VV; Maliborska SV
Exp Oncol; 2022 Dec; 44(4):300-306. PubMed ID: 36811539
[TBL] [Abstract][Full Text] [Related]
25. Effect of Vitamin E on Oxaliplatin-induced Peripheral Neuropathy Prevention: A Randomized Controlled Trial.
Salehi Z; Roayaei M
Int J Prev Med; 2015; 6():104. PubMed ID: 26682028
[TBL] [Abstract][Full Text] [Related]
26. Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.
Xiao WH; Zheng H; Bennett GJ
Neuroscience; 2012 Feb; 203():194-206. PubMed ID: 22200546
[TBL] [Abstract][Full Text] [Related]
27. Corneal Nerve Changes Observed by In Vivo Confocal Microscopy in Patients Receiving Oxaliplatin for Colorectal Cancer: The COCO Study.
Tyler EF; McGhee CNJ; Lawrence B; Braatvedt GD; Mankowski JL; Oakley JD; Sethi S; Misra SL
J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013010
[TBL] [Abstract][Full Text] [Related]
28. Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.
Areti A; Komirishetty P; Kalvala AK; Nellaiappan K; Kumar A
Mol Neurobiol; 2018 Sep; 55(9):7463-7475. PubMed ID: 29427084
[TBL] [Abstract][Full Text] [Related]
29. Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir.
Coriat R; Alexandre J; Nicco C; Quinquis L; Benoit E; Chéreau C; Lemaréchal H; Mir O; Borderie D; Tréluyer JM; Weill B; Coste J; Goldwasser F; Batteux F
J Clin Invest; 2014 Jan; 124(1):262-72. PubMed ID: 24355920
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of alpha-lipoic acid on hair cell damage in diabetic zebrafish model.
Kim E; Lee DW; Park HC; Kim DH
Mol Genet Metab Rep; 2021 Sep; 28():100783. PubMed ID: 34354927
[TBL] [Abstract][Full Text] [Related]
31. Metformin Preserves Peripheral Nerve Damage with Comparable Effects to Alpha Lipoic Acid in Streptozotocin/High-Fat Diet Induced Diabetic Rats.
Kim SH; Park TS; Jin HY
Diabetes Metab J; 2020 Dec; 44(6):842-853. PubMed ID: 32602278
[TBL] [Abstract][Full Text] [Related]
32. [Curative effect of alpha-lipoic acid on peripheral neuropathy in type 2 diabetes: a clinical study].
Liu F; Zhang Y; Yang M; Liu B; Shen YD; Jia WP; Xiang KS
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2706-9. PubMed ID: 18167250
[TBL] [Abstract][Full Text] [Related]
33. Protective effects of phosphatidylcholine on oxaliplatin-induced neuropathy in rats.
Kim ST; Chung YH; Lee HS; Chung SJ; Lee JH; Sohn UD; Shin YK; Park ES; Kim HC; Bang JS; Jeong JH
Life Sci; 2015 Jun; 130():81-7. PubMed ID: 25817232
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective Effect of Baicalein Against Oxaliplatin-Induced Peripheral Neuropathy: Impact on Oxidative Stress, Neuro-inflammation and WNT/β-Catenin Signaling.
Jugait S; Areti A; Nellaiappan K; Narwani P; Saha P; Velayutham R; Kumar A
Mol Neurobiol; 2022 Jul; 59(7):4334-4350. PubMed ID: 35527292
[TBL] [Abstract][Full Text] [Related]
35. Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats.
Fujita S; Ushio S; Ozawa N; Masuguchi K; Kawashiri T; Oishi R; Egashira N
PLoS One; 2015; 10(11):e0141921. PubMed ID: 26536615
[TBL] [Abstract][Full Text] [Related]
36. Oxaliplatin treatment and peripheral nerve damage in cancer patients: A Polish cohort study.
Banach M; Zygulska AL; Krzemieniecki K
J Cancer Res Ther; 2018; 14(5):1010-1013. PubMed ID: 30197340
[TBL] [Abstract][Full Text] [Related]
37. Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study.
El-Nahas MR; Elkannishy G; Abdelhafez H; Elkhamisy ET; El-Sehrawy AA
Endocr Metab Immune Disord Drug Targets; 2020; 20(9):1531-1534. PubMed ID: 32370731
[TBL] [Abstract][Full Text] [Related]
38. Identification of drug transporters contributing to oxaliplatin-induced peripheral neuropathy.
Fujita S; Hirota T; Sakiyama R; Baba M; Ieiri I
J Neurochem; 2019 Feb; 148(3):373-385. PubMed ID: 30295925
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup.
Kerckhove N; Busserolles J; Stanbury T; Pereira B; Plence V; Bonnetain F; Krakowski I; Eschalier A; Pezet D; Balayssac D
BMJ Open; 2019 Jun; 9(6):e027770. PubMed ID: 31182448
[TBL] [Abstract][Full Text] [Related]
40. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.
Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC
Brain; 2009 Oct; 132(Pt 10):2712-23. PubMed ID: 19745023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
